title: Thyroid C-cell hyperplasia shown by combined In-111 pentetreotide, Tc-99m pertechnetate, and Tc-99m MIBI scintigraphy.
authors: Nuclear Medicine Unit, Department of Diagnostic Medical Sciences, Padua University Hospital, Italy. diego.cecchin@unipd.it
authors: Diego
authors: D
authors: Cecchin
authors: Franco
authors: F
authors: Lumachi
authors: Filippo
authors: F
authors: Marino
authors: Roberto
authors: R
authors: Stramare
authors: Umberto
authors: U
authors: Basso
authors: Gaia
authors: G
authors: Grassetto
authors: Franco
authors: F
authors: Bui
mesh_terms: D000236:Adenoma / Q000473:pathology; D049109:Cell Proliferation; D015179:Colorectal Neoplasms / Q000473:pathology; D003937:Diagnosis, Differential; D006801:Humans; D006965:Hyperplasia; D007205:Indium Radioisotopes / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D013670:Sodium Pertechnetate Tc 99m / Q000494:pharmacology*; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000494:pharmacology; D017256:Technetium Tc 99m Sestamibi / Q000494:pharmacology*; D013961:Thyroid Gland / Q000473:pathology*; D013964:Thyroid Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000556:secondary; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods*
chemical_list: D007205:Indium Radioisotopes; D013004:Somatostatin; D017256:Technetium Tc 99m Sestamibi; D013670:Sodium Pertechnetate Tc 99m; C081788:pentetreotide